XIAP and inflammatory bowel disease: For example, around 20–30% of patients with XIAP deficiency or with GSD-1b caused by SLC374A4 demonstrate an IBD-like phenotype (16, 25, 26) and 4–9% with Wiskott Aldrich Syndrome develop IBD (27, 28).